Ventus Medical, Inc., based in Belmont, CA, is focused on transforming treatment of sleep disordered breathing. Its lead product is PROVENT Sleep Apnea Therapy, a daily-use, prescription device indicated for the treatment of obstructive sleep apnea. The company closed a $40M Series D financing to support growth. The new capital will enable Ventus to expand commercialization efforts for PROVENT. In conjunction with the funding, Ventus named Peter Wyles as President and CEO. Wyles was most recently with Bayer HealthCare for 15 years and previously led the expansion and integration of Metrika after its acquisition.

Total raised

$40M

Funding rounds

1

Latest round

Series D

Latest activity

Jul 2010